You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In Genome Research this week: a physical and genetic map of Cannabis sativa, evaluation of family- and population-based imputation tools, and more.
With a DNA methylation atlas and deconvolution algorithm, researchers are attempting to trace cfDNA back to tissue sources in healthy or ill individuals.
The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.
In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.
The Fertilome test, a multigene sequencing panel, assesses a number of markers that have been associated with conditions that affect fertility.
In an opinion piece at the Guardian, the National History Museum's Michael Dixon says the removal of Darwin and evolution from school curriculum is worrisome.
The deal will join CGI's portfolio of cancer tests and lab services with NovellusDx's technologies for cancer treatment response prediction.
NovellusDx's assay is designed to test the functional effects of variants of unknown significance in response to various cancer treatments to predict clinical results.
The Israeli companies will use NRGene's computational tools to develop DNA-based biomarkers for medical cannabis breeding and strain identification.
Retraction Watch writes that a cancer researcher has had an eighth paper retracted.
Computational biologist James Taylor has died, according to Johns Hopkins University.
The Centers for Disease Control and Prevention is starting to test people for SARS-CoV-2 antibodies, according to the New York Times.
In PLOS this week: features of tumor-infiltrating immune cells, regulatory effects of SNPs associated with prostate cancer risk, and more.